Spyryx Biosciences, Inc.

Industry

  • Pharmaceuticals
    • Drug Delivery
      • Pulmonary
      • Macromolecule
  • Biotechnology
    • Large Molecule
See more in Biomedtracker

Latest on Spyryx Biosciences, Inc.

Scrip

Pipeline Watch: Phase III Progress With Nimotuzumab, Solriamfetol, And Upadacitinib

 
• By John Davis

The progression of investigational products through a series of increasingly sophisticated and targeted clinical trials is a well-tried and tested route for the development of new medicines for commer

Scrip

Start-Up Execs On The Move, June 2015

 
• By Regina Paleski

Start-Up Execs Cristal Therapeutics Jeroen Tonnaer, PhD To: CBO (April) From: Merck & Co. Inc. Phone: +31 433 88 58 68 Editas Medicine Inc. Vic Myer, PhD To: CTO (April) From: Exec. Dir.

Scrip

Venture Funding Deals, June 2015

 
• By Deanna Kamienski, Beth Allan, Amanda Micklus, Maureen Riordan, and Steven Muntner

IN VITRO DIAGNOSTICS Abcodia Ltd. Abcodia brings in £5.25mm through Series A round Cancer diagnostics company Abcodia Ltd. raised £5.25mm ($8.2mm) through what appears to be its Series A round

In Vivo

Out Of The Blocks, March 2015

 
• By Nancy Dvorin

[Capsos Medical Ltd.] Innovation in Business Centre, GMIT Dublin Road Galway, Ireland Phone: + 353 91 386 660 Email: info@capsosmedical.com Web Site: www.capsosmedical.com Management: Brendan McLaugh